<PAGE> 1
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON AUGUST 8, 2000
REGISTRATION NO. 333-31140
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------
AMENDMENT NO. 5
TO
FORM S-1
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
---------------------------
ATHEROGENICS, INC.
(Exact name of Registrant as specified in its charter)
<TABLE>
<S> <C> <C>
GEORGIA 2834 58-2108232
(State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer
incorporation or organization) Classification Code Number) Identification Number)
</TABLE>
8995 WESTSIDE PARKWAY
ALPHARETTA, GEORGIA 30004
(678) 336-2500
(Address, including zip code, and telephone number,including area code,
of Registrant's principal executive offices)
---------------------------
RUSSELL M. MEDFORD, M.D., PH.D.
PRESIDENT AND CHIEF EXECUTIVE OFFICER
ATHEROGENICS, INC.
8995 WESTSIDE PARKWAY
ALPHARETTA, GEORGIA 30004
(678) 336-2500
(Name, address, including zip code, and telephone number, including area code,
of agent for service)
---------------------------
Copies to:
<TABLE>
<S> <C>
LEONARD A. SILVERSTEIN, ESQ. ALAN L. JAKIMO, ESQ.
LONG ALDRIDGE & NORMAN LLP BROWN & WOOD LLP
SUNTRUST PLAZA, SUITE 5300 ONE WORLD TRADE CENTER, 58TH FLOOR
303 PEACHTREE STREET NEW YORK, NEW YORK 10048
ATLANTA, GEORGIA 30308-3201 (212) 839-5300
(404) 527-4000
</TABLE>
---------------------------
APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC: As soon as
practicable after this Registration Statement becomes effective.
If any of the securities registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act, check
the following box. [ ]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [ ]
---------------------------
<TABLE>
<CAPTION>
CALCULATION OF REGISTRATION FEE
===============================================================================================================
<S> <C> <C> <C> <C>
PROPOSED PROPOSED
MAXIMUM MAXIMUM
TITLE OF EACH AMOUNT OFFERING AGGREGATE AMOUNT OF
CLASS OF SECURITIES TO BE PRICE PER OFFERING REGISTRATION
TO BE REGISTERED REGISTERED UNIT PRICE (1)(2) FEE(3)
---------------------------------------------------------------------------------------------------------------
Common Stock, no par value per share 6,900,000 shares $13.00 $89,700,000 $23,680.80
===============================================================================================================
</TABLE>
(1) Includes the dollar value of shares that the underwriters have the
option to purchase to cover over-allotments, if any.
(2) Estimated solely for the purpose of calculating the amount of the
registration fee pursuant to Rule 457(a) under the Securities Act.
(3) This amount has been previously paid.
THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR
DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL
FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF
THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A),
MAY DETERMINE.
================================================================================
<PAGE> 2
EXPLANATORY NOTE
The purpose of this Amendment No. 5 to the Registration Statement is
solely to change the calculation of the proposed maximum aggregate offering
price in the "Calculation of Registration Fee" table on the cover page of the
Registration Statement from $100,000,000 to $89,700,000 to reflect the estimated
maximum initial public offering price of $13.00 per share and the amount of
shares to be registered. There are no changes to the prospectus that forms a
part of the Registration Statement or to Part II of the Registration Statement.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
has duly caused this amendment to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Atlanta, State of Georgia, on
August 8, 2000.
ATHEROGENICS, INC.
By:/s/ RUSSELL M. MEDFORD, M.D., PH.D.
---------------------------------------
RUSSELL M. MEDFORD, M.D., PH.D.
President and Chief Executive Officer
PURSUANT TO THE REQUIREMENTS OF THE SECURITIES ACT OF 1933, THIS AMENDMENT
HAS BEEN SIGNED BY THE FOLLOWING PERSONS IN THE CAPACITIES AND ON THE DATES
INDICATED:
<TABLE>
<CAPTION>
NAME TITLE DATE
---- ----- ----
<C> <S> <C>
PRINCIPAL EXECUTIVE OFFICER:
/s/ RUSSELL M. MEDFORD President and Chief Executive August 8, 2000
------------------------------------------------ Officer, Director
RUSSELL M. MEDFORD
PRINCIPAL FINANCIAL AND PRINCIPAL
ACCOUNTING OFFICER:
/s/ MARK P. COLONNESE Vice President of Finance and August 8, 2000
------------------------------------------------ Administration and Chief
MARK P. COLONNESE Financial Officer
ADDITIONAL DIRECTORS:
* Director August 8, 2000
------------------------------------------------
MICHAEL A. HENOS
* Director August 8, 2000
------------------------------------------------
R. WAYNE ALEXANDER
* Director August 8, 2000
------------------------------------------------
VAUGHN D. BRYSON
* Director August 8, 2000
------------------------------------------------
T. FORCHT DAGI
* Director August 8, 2000
------------------------------------------------
VIJAY K. LATHI
* Director August 8, 2000
------------------------------------------------
ARDA MINOCHERHOMJEE
* Director August 8, 2000
------------------------------------------------
ARTHUR M. PAPPAS
* Director August 8, 2000
------------------------------------------------
RICHARD S. SCHNEIDER
[Signatures continued on following page.]
</TABLE>
<PAGE> 4
<TABLE>
<CAPTION>
NAME TITLE DATE
---- ----- ----
<C> <S> <C>
* Director August 8, 2000
------------------------------------------------
WILLIAM A. SCOTT
*By: /s/ MARK P. COLONNESE
------------------------------------------
Mark P. Colonnese
Attorney-in-fact
</TABLE>
